Caffeine Effects on Antiepileptic Drug Efficacy

Caffeine, the world’s most widely consumed psychoactive substance, exerts its stimulant effects chiefly through antagonism of central adenosine receptors. In preclinical seizure models, even subconvulsive doses of caffeine have been shown to diminish the anticonvulsant potency of a broad range of antiepileptic drugs, including carbamazepine, phenobarbital, phenytoin and valproate. Intriguingly, certain agents such as lamotrigine and oxcarbazepine appear resistant to this interaction, a phenomenon tentatively ascribed to their inhibition of R-type calcium channels. These findings suggest that caffeine may interfere with the ion-channel and neurotransmitter targets essential for seizure control. Clinical observations remain mixed: small series report increased seizure frequency with high caffeine intake, whereas larger cohorts have failed to confirm a detrimental effect. The global prevalence of both epilepsy and caffeine consumption underscores the need to clarify these interactions. Understanding when and how caffeine modulates drug efficacy has immediate implications for patient guidance, therapeutic monitoring and the development of drug regimens that are robust to dietary stimulant use.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Caffeine Effects on Antiepileptic Drug Efficacy publication trend

The graph below shows the total number of articles in caffeine effects on antiepileptic drug efficacy across all publications each year (not limited to Nature Index journals).

Technical terms

Antiepileptic (Antiseizure) medications (ASMs): Drugs that modulate neuronal excitability or synaptic transmission to prevent or reduce seizure activity.

Adenosine receptors: G-protein coupled receptors whose activation produces inhibitory neuromodulation; caffeine blocks these receptors to exert stimulant effects.

R-type calcium channels: Subset of voltage-gated calcium channels contributing to neurotransmitter release; their blockade supports seizure suppression.

Pentylenetetrazol (PTZ) seizure model: A convulsant assay in which PTZ induces seizure-like behaviour in animals or larvae, enabling assessment of anticonvulsant efficacy.

Liquid chromatography–mass spectrometry (LC-MS/MS): Analytical technique combining chromatographic separation with mass detection, used to quantify drugs and metabolites in biological samples.

References

1. Caffeine and Its Interactions with Antiseizure Medications—Is There a Correlation between Preclinical and Clinical Data?. International Journal of Molecular Sciences (2023).
2. Optimization of the Zebrafish Larvae Pentylenetetrazol-Induced Seizure Model for the Study of Caffeine and Topiramate Interactions. International Journal of Molecular Sciences (2023).
3. Caffeine Decreases Topiramate Levels in Zebrafish Larvae in a Pentylenetetrazol-Induced Seizure Model. International Journal of Molecular Sciences (2024).